Plasma amino acid concentrations in patients with coronary heart disease: A comparison between UK Indian Asian and Caucasian men

International Journal for Vitamin and Nutrition Research

Volumn 75, Issue 4, 2005, Pages 267-273

  Obeid, Omar A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Amino acids; CHD; UK Indian Asian

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CITRULLINE; CYSTEINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; HOMOCYSTEINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; MALE; RACE DIFFERENCE;

ALANINE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY DISEASE; CYSTEINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEEDING BEHAVIOR; HUMANS; MALE; MIDDLE AGED;

EID: 24744470723     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.75.4.267     Document Type: Article

References (45)

1. Ilzecka, J., Stelmasiak, Z., Solski, J., Wawrzycki, S. and Szpetnar, M. (2003) Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids 25 (1), 69-73.
2. Yoneda, T., Yoshikawa, M., Fu, A., Tsukaguchi, K., Okamoto, Y. and Takenaka, H. (2001) Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. Nutrition 17, 95-99.
3. Muscaritoli, M., Conversano, L., Petti, M.C., Torelli, G.F., Cascino, A., Mecarocci, S., Annicchiarico, M.A. and Rossi Fanelli, F. (1999) Plasma amino acid concentrations in patients with acute myelogenous leukemia. Nutrition 15 (3), 195-199.
4. Norton, J.A., Gorschboth, C.M., Wesley, R.A., Burt, M.E. and Brennan, M.F. (1985) Fasting plasma amino acid levels in cancer patients. Cancer 56 (5), 1181-6.
5. Aguilo, A., Castano, E., Tauler, P., Guix, M.P., Serra, N. and Pons, A. (2000) Participation of blood cells in the changes of blood amino acid concentrations during maximal exercise. J. Nutr. Biochem. 11, 81-86.
6. Proenza, A.M., Roca, P., Crespi, C., Llado, I. and Palou, A. (1998) Blood amino acid compartmentation in men and women with different degrees of obesity. J. Nutr. Biochem. 9, 697-704.
7. Nittynen, L., Nurminen, M.L., Korpela, R. and Vapaatalo, H. (1999) Role of arginine, taurine and homocysteine in cardiovascular diseases. Ann. Med. 33, 318-326.
8. Cooke, J.P. and Tsao, P.S. (1997) Arginine: a new therapy for atherosclerosis? Circulation 95, 311-312.
9. El-Khairy, L., Ueland, P.M., Refsum, H., Graham, I.M. and Vollset, S.E. (2001) Plasma total cysteine as a risk factor for vascular disease: the European concerted action project. Circulation 103, 2544-2549.
10. Hankey, J.H. and Eikelboom, J.W. (1999) Homocysteine and vascular disease. Lancet 354, 407-413.
11. Clarke, R., Daly, L. and Robinson, K. (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155.
12. Graham, I.M., Daly, L.E. and Refsum, H.M. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277, 1775-1781.
13. Nygard, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M. and Vollset, S. E. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337, 230-236.
14. Stampfer, M.J., Malinow, M.R. and Willett, W.C. (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-881.
15. Chambers, J.C., Obeid, O.A., Refsum, H., Ueland, P., Hackett, D., Hooper, J., Turner, R.M., Thompson, S.G. and Kooner, J.S. (2000) Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355, 523-527.
16. Danesh, J. and Lewington, S. (1998) Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J. Cardiovasc. Risk 5, 229-232.
17. Welch, G.N. and Loscalzo, J. (1998) Homocysteine and atherothrombosis. N. Eng. J. Med. 338, 1042-1050.
18. Moghadasian, M.H., McManus, B.M. and Frohlich, J.J. (1997) Homocysteine and coronary artery disease: clinical evidence and genetic and metabolic background. Arch. Intern. Med. 157, 2299-2308.
19. Leklem, J.E. (2001) Vitamin B6. In: Handbook of vitamins (Rucker, et al, eds.). 3rd edition, pp. 339-396, Marcel Dekker, Basel, New York.
20. Aboaysha, A.M. and Kratzer, F.H. (1979) Interrelationships between dietary pyridoxine and free plasma amino acids in chicks. Poultry Sci. 58, 117-123.
21. Folsom, A.R., Javier, N.F., McGovern, P.G., Tsai, M.Y., Malinow, M.R., Eckfeldt, J.H., Hess, D.L. and Davis, C.E. (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins: the atherosclerosis risk in communities (ARIC) study. Circulation 98, 204-210.
22. Robinson, K., Mayer, E.L., Miller, D.P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S.R., Selhub, J., Nissen, S., Kutner, M., Topol, E.J. and Jacobsen, D. W. (1995) Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825-2830.
23. Ubbink, J.B., Vermaak, W.H.J. and Bissbort, S. (1991) Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatography 565, 441-446.
24. Brody, T. and Shane, B. (2001) Folic acid. In: Handbook of vitamins (Rucker, et al, eds.). 3rd edition, pp. 427-462, Marcel Dekker, Basel, New York.
25. Yamori, Y., Nara, Y., Ikeda, K. and Mizushima, S. (1996) Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? In: Taurine 2 (Huxtable, R., Azuma, J., Kuriyama, K., Nakagawa, M. and Baba, A., eds.), Adv. Exp. Med. Biol. 403, pp. 623-629, Plenum Press, New York.
26. Yamori, Y., Liu, L., Ikeda, K., Miura, A., Mizushima, S., Miki, T. and Nara, Y. (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens. Res. 24, 453-457.
27. Huxtable, R.J. (1992) Physiological actions of taurine. Physiol. Rev. 72, 101-63.
28. Cooke, J.P. and Tsao, P.S. (1994) Is NO an antiatherogenic molecule? Arterioscler. Thromb. 14, 653-655.
29. Yalow, R.S. and Berson, S.A. (1960) Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39, 1157.
30. Knopf, R.F., Fajans, S.S., Floyd Jr., J.C. and Conn, J.W. (1963) Comparison of experimentally induced and naturally occurring sensitivity to leucine hypoglycemia. J. Clin. Endocrinol. Metab. 23, 579-587.
31. Balarajan, R. (1996) Ethnicity and variations in mortality from coronary heart disease. Health Trends 28, 45-51.
32. McKeigue, P.M., Shah, B. and Marmot, M.G. (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337, 382-386.
33. McKeigue, P.M., Ferrie, J.E., Pierpoint, T. and Marmot, M.G. (1993) Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 87, 152-161.
34. Mather, H.M. and Keen, H. (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br. Med. J. 291, 1081-1084.
35. te Poele-Pothoff, et al. (1995) Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 32, 218-220.
36. 6 status on homocysteine metabolism. J. Clin. Invest. 98, 177-184.
37. Mann, G.E., Smith, S., Norman, P.S.R. and Emery, P.W. (1988) Fasting, refeeding and diabetes modulate free amino acid concentrations in the rat exocrine pancreas: role of transstimulation in amino acid efflux. Pancreas 3, 67-76.
38. Bates, C.J., Pentieva, K.D., Matthews, N. and Macdonald, A. (1999) A simple, sensitive and reproducible assay for pyridoxal-5-phosphate and 4-pyridoxic acid in human plasma. Clin. Chim. Acta 280, 101-111.
39. Institute of Medicine (2002) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). pp. 465-608, National Academy Press, Washington, D.C.
40. Grimble, R.F. (2001) Nutritional modulation of immune function. Proc. Nutr. Soc. 60, 389-397.
41. Suliman, M.E., Stenvinkel, P., Qureshi, A.R., Barany, P., Heimburger, O., Anderstam, B., Alvestrand, A. and Lindholm, B. (2004) Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am. J. Kidney Dis. 44(3), 455-65.
42. Krentz, A.J., Singh, B.M. and Nattrass, M. (1991) Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism. Diabet. Med. 8(9), 848-854.
43. 12) Handbook of vitamins (Rucker, et al eds.). 3rd edition, pp 463-512, Marcel Dekker, Basel, New York.
44. Hutchesson, A.C., Bundey, S., Preece, M.A., Hall, S.K. and Green, A. (1998) A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J. Med. Genet. 35(5), 366-70.
45. Jeserich, M., Munzel, T., Just, H. and Drexler, H. (1992) Reduced plasma L-arginine in hypercholesterolaemia. Lancet 339, 561.